Webinar live date: Wednesday 2nd September 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. This webinar will discuss the applications of ELISpot assays to detect cellular immune responses to specific antigens associated with viral vector-based gene therapies.
Webinar live date: Thursday 13 August 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Register for our exclusive Coffee Chat focusing on the quantification of biologics by LC–MS. This informal discussion centers around the use of bioanalytical strategies to support the development of bringing new biologics to market.
Webinar available on demand. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion. The panel discussion focuses on new methods, the new age of biomarkers and current trends in non-standard bioanalytical techniques.
Webinar available on demand. This webinar will discuss how multi-parameter flow cytometry can be used to confidently detect, characterizeand quantitate rare-cell populations for clinical development applications.
Read expert answers to audience submitted questions during the recent panel discussion – COVID-19 and patient-centric sampling: how to fight a pandemic.
Webinar available on demand. Join us for an in-depth bioanalytical and clinical exploration, including case studies, of microsampling technology and its significance in supporting patient-centric healthcare initiatives.
Webinar available on demand. In this webinar, we will investigate ligand binding assays (LBAs) and LC–MS/MS generic PK methods for the quantification of therapeutic monoclonal antibodies in pre-clinical species.
Panel discussion available on demand. In this free panel discussion, our experts will provide insights into their own research and involvement with biomarker discovery including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.
Webinar available on demand. Learn how LC–MS/MS targeted quantification approaches can provide the highest possible sensitivity and selectivity for host cell proteins for biotherapeutic production.
Webinar available on demand. As COVID-19 is shutting down countries, particularly locking down travel, we discuss the impact on blood sample collection and how a patient-centric sampling approach could help mitigate these challenges and how the approach could be part of our new normal.
Webinar available on demand. Development and optimization of a fit-for-purpose, fully qualified biotherapeutic PK assay on a microfluidic, automated immunoassay platform enhances workflow efficiency and minimizes human error.
Webinar available on demand. With the ongoing COVID-19 pandemic extensively impacting clinical trials irrespective of indication, learn how bioequivalence studies (BCS) can be a suitable stop-gap measure in the interim.
Researchers from the University of Birmingham (Birmingham, UK) and Newcastle University (Newcastle, UK) have investigated a key enzyme utilized by gut bacteria that could be developed as a biomarker for intestinal diseases.
I have the great pleasure to announce that the 24th Reid International Bioanalytical Forum will be held on the 20–23 September 2021…
At a time where the world is looking to repurposed drugs to give the quickest treatment option to the COVID-19 pandemic, we interview David Fajgenbaum (University of Pennsylvania (PA, USA) and bestselling author of ‘Chasing My Cure’) on what type of treatment he considers to hold the most promise.
Jisun HJ Lee and Jiangjiang Zhu discuss volatile organic compounds produced by the gut microbiome and their relationship with human health. They also examine volatilomics, a field of metabolomics dedicated to the detection and quantification of gut microbial volatile compounds to reveal their function in human health and metabolism.
In this interview, Chris Zhu (The Ohio State University) discusses what mass spectrometry-based volatilomics techniques currently exist and how these can be used to analyze biological samples.